AI in Cancer Diagnostics Market Size, Key Trends, and Forecast for 2024 Insights: Quintile Reports

PUNE, India - Oct. 5, 2024 - PRLog -- Quintile Reports published a research, titled, "AI in Cancer Diagnostics Market Size Estimation, Share & Future Growth Trends Analysis, By Technology (Machine Learning, Deep Learning), By Application, By Cancer Type, By Diagnosis Type, By End-User Type, and Regional Analysis, 2024-2034"

According to the report, the AI in Cancer Diagnostics Market was estimated at $1.29 billion in 2023 and is projected to reach $10.46 billion by 2034, reflecting a robust CAGR of 28.26% over the forecast period from 2024 to 2034. The AI in Cancer Diagnostics market report offers a comprehensive and nuanced view of the industry, moving beyond conventional analysis.

The following organizations are recognized as the Key Players in the Global AI in Cancer Diagnostics Market Research Report:

IBM Watson Health, Google Health (DeepMind), Microsoft, EarlySign, Cancer Center.ai, Microsoft, Flatiron, Path AI, Therapixel, Tempus, Paige AI, Inc., Kheiron Medical Technologies Limited, SkinVision, Tempus Labs, NVIDIA Corporation, Others.

Get Free Sample PDF + All Related Graphs & Charts + Purchase Options @ https://www.quintilereports.com/industry-report/779-ai-in...